Scienture Holdings Inc. Common Stock (SCNX)
Stock · NASDAQ · Health Care
$3.33as of 10/16/2026
Price chart
Active signals
SCNX Signal Track Record
How signals performed across all stocks →What SCNX's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 31 | -14.5% | 29% | October 2, 2026 |
| Bollinger Band Breakdown | 21 | -6.7% | 43% | September 22, 2026 |
| Bollinger Band Breakout | 18 | +0.7% | 50% | October 5, 2026 |
| 200-Day Moving Average TouchActive now | 9 | -2.1% | 44% | November 13, 2024 |
| Any 20-session window (baseline) | -9.0% | 34% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About SCNX
Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. The company develops SCN-102, an oral liquid formulation of losartan potassium that is in phase 1 for the treatment of hypertension, diabetic nephropathy, and reduction of the risk of stroke in patients w…
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Employees
- 4
- Website
- www.trxadehealth.com/
Fundamentals
- 1-day range
- $3.25$3.42
- Market cap
- $15.14M
- P/E (trailing)
- —
- P/E (forward)
- Infinity
- EPS (trailing)
- $-8.63
- Dividend yield
- —
- Beta
- 3.24
- Avg. volume
- 188.9K
- Ex-dividend date
- July 19, 2024
- Dividend pay date
- July 24, 2024
How Scienture Holdings Inc. Common Stock Makes Money
Where the revenue actually goes — FY2025 annual results
Source: 10-K filed Mar 30, 2026 · via SEC EDGAR / Finnhub
Forecasts
1 analyst ratings
Scienture Holdings Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- SCNXScienture Holdings Inc. Common Stock$3.36▼ 0.59%Market cap $15.14MP/E —$3.21$65
- HINDVyome Holdings Inc. Common Stock$1.87▼ 2.09%Market cap $15.02MP/E —$1.75$6.56
- KTTAPasithea Therapeutics Corp. Common Stock$0.42▲ 2.44%Market cap $14.82MP/E —$0.281$2.06
- TPSTTempest Therapeutics Inc. Common Stock$0.624▼ 1.73%Market cap $14.42MP/E —$0.6801$12.23
- BFRIBiofrontera Inc. Common Stock$0.822▼ 2.95%Market cap $16.00MP/E —$0.555$1.66
- KALAKALA BIO Inc. Common Stock$0.19▼ 1.04%Market cap $14.25MP/E —$0.2593$95.5
- COCPCocrystal Pharma Inc. Common Stock$1.02▼ 0.97%Market cap $14.20MP/E —$0.76$2.03
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| SCNX Scienture Holdings Inc. Common Stock | $15.14M | — | $3.36 | ▼ 0.59% | $3.21$65 |
| HIND Vyome Holdings Inc. Common Stock | $15.02M | — | $1.87 | ▼ 2.09% | $1.75$6.56 |
| KTTA Pasithea Therapeutics Corp. Common Stock | $14.82M | — | $0.42 | ▲ 2.44% | $0.281$2.06 |
| TPST Tempest Therapeutics Inc. Common Stock | $14.42M | — | $0.624 | ▼ 1.73% | $0.6801$12.23 |
| BFRI Biofrontera Inc. Common Stock | $16.00M | — | $0.822 | ▼ 2.95% | $0.555$1.66 |
| KALA KALA BIO Inc. Common Stock | $14.25M | — | $0.19 | ▼ 1.04% | $0.2593$95.5 |
| COCP Cocrystal Pharma Inc. Common Stock | $14.20M | — | $1.02 | ▼ 0.97% | $0.76$2.03 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- SCIENTURE HOLDINGS Reports Preliminary Q3 Revenue Of ~$1.22Mbenzinga · 10/13/2026
- What's going on in today's pre-market sessionChartMill · 10/6/2026
- Curious about the stocks that are showing activity after the closing bell on Friday?ChartMill · 10/2/2026
- Which stocks are most active on Friday?ChartMill · 10/2/2026
- Friday's pre-market session: top gainers and losersChartMill · 10/2/2026
- SCIENTURE Announces Arbli™ Added to Formularies at Three Leading U.S. Pediatric Academic Medical Centers and HospitalsYahoo · 10/2/2026
- EXCLUSIVE: Scienture Expands Institutional Reach for Hypertension Drug with New Hospital AdoptionsYahoo · 10/2/2026
- Which stocks are experiencing notable movement on Thursday?ChartMill · 10/1/2026
- Thursday's session: gap up and gap down stocksChartMill · 10/1/2026
Institutional Ownership
March 31, 2026
- Total shares held
- 1.22M
- Total value held
- $324.7K
- Institutional holders
- 13
- Unknown432.2K
- Unknown408.1K
- Unknown107.8K
- Unknown84.2K
- Unknown47.7K
- Unknown44.8K
- Unknown36.4K
- Unknown27.6K
- Unknown15.0K
- Unknown13.9K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 1, 2026
SCNX Shares Drop 19% After Hours Amid Reverse Split
SCNX shares fell 19% in after‑hours trading after the company announced a reverse stock split. The reverse split will consolidate shares, potentially raising the share price but also reducing the number of shares outstanding. The drop comes while the stock sits near its 12‑month low and has a very low RSI, indicating a possible oversold condition. The reverse split may be a move to meet listing requirements and support future trading.
SCNX Shares Drop 19% After Hours Amid Reverse Split. SCNX shares fell 19% in after‑hours trading after the company announced a reverse stock split. The reverse split will consolidate shares, potentially raising the share price but also reducing the number of shares outstanding. The drop comes while the stock sits near its 12‑month low and has a very low RSI, indicating a possible oversold condition. The reverse split may be a move to meet listing requirements and support future trading.